Literature DB >> 7630627

B cell differentiation: role of E2A and Pax5/BSAP transcription factors.

S J Baker1, E P Reddy.   

Abstract

Transcriptional regulation of lineage specific genes has the ability to dictate both the proliferative and differentiative potentials of a pluipotent precursor cell. The E2A and Pax5/BSAP genes encode transcription factors which bind to B cell specific promoters and enhancers and guide the development of immature, but committed cells into mature B lymphocytes which express and secrete immunoglobulins. In vitro analysis has consistently suggested that these proteins regulate distinct classes of genes during B cell differentiation; however, recent targeted gene disruption and transgene expression in mice has indicated that these genes may actually be components of a single regulatory mechanism which is essential for both B lymphocyte differentiation and proliferation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7630627

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

1.  Flanking sequences modulate the cell specificity of M-CAT elements.

Authors:  S B Larkin; I K Farrance; C P Ordahl
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

2.  Regulation of Id3 cell cycle function by Cdk-2-dependent phosphorylation.

Authors:  R W Deed; E Hara; G T Atherton; G Peters; J D Norton
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

3.  Role for homodimerization in growth deregulation by E2a fusion proteins.

Authors:  R Bayly; D P LeBrun
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

4.  Modeling early Epstein-Barr virus infection in Drosophila melanogaster: the BZLF1 protein.

Authors:  Amy L Adamson; Natasha Wright; Dennis R LaJeunesse
Journal:  Genetics       Date:  2005-08-03       Impact factor: 4.562

5.  A human non-XLA immunodeficiency disease characterized by blockage of B cell development at an early proB cell stage.

Authors:  E Meffre; F LeDeist; G de Saint-Basile; A Deville; M Fougereau; A Fischer; C Schiff
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

6.  Increased expression of bHLH transcription factor E2A (TCF3) in prostate cancer promotes proliferation and confers resistance to doxorubicin induced apoptosis.

Authors:  Divya Patel; Jaideep Chaudhary
Journal:  Biochem Biophys Res Commun       Date:  2012-04-30       Impact factor: 3.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.